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Occupational asthma is the most common form of occupational lung disease in the developed
world at the present time. In this review, the epidemiology, pathogenesis/mechanisms, clinical
presentations, management, and prevention of occupational asthma are discussed. The population
attributable risk of asthma due to occupational exposures is considerable. Current understanding of
the mechanisms by which many agents cause occupational asthma is limited, especially for low-
molecular-weight sensitizers and irritants. The diagnosis of occupational asthma is generally
established on the basis of a suggestive history of a temporal association between exposure and
the onset of symptoms and objective evidence that these symptoms are related to airflow
limitation. Early diagnosis, elimination of exposure to the responsible agent, and early use of
inhaled steroids may play important roles in the prevention of long-term persistence of asthma.
Persistent occupational asthma is often associated with substantial disability and consequent
impacts on income and quality of life. Prevention of new cases is the best approach to reducing
the burden of asthma attributable to occupational exposures. Future research needs are identified.
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Work-related asthma is the most common
form of occupational lung disease, causing
significant morbidity and disability. Work-
related asthma may be categorized into occu-
pational asthma, which refers to new-onset
asthma caused by exposure at the workplace,
and work-aggravated asthma, in which pre-
existing asthma is exacerbated.
In this review, the epidemiology, patho-
genesis/mechanisms, and clinical presenta-
tions of occupational asthma (both sensitizer-
and irritant-induced) are discussed. A diag-
nostic approach is presented, including his-
tory and exposure assessment, physical
examination, and objective tests used to con-
firm both the diagnosis and work-relatedness
of asthma. Management of the worker with
occupational asthma is also addressed, includ-
ing work modifications, prognosis, and
impairment/disability assessment. Finally, the
prevention of occupational asthma and future
research needs are highlighted.
Definition/Classification
of Occupational Asthma
Workplace exposure is an important cause of
both new-onset asthma and exacerbations of
preexisting disease. Although the term occu-
pational asthma usually refers to new-onset
asthma caused by exposure at the workplace,
exacerbations of preexisting asthma are a
potentially more important cause of morbid-
ity because there are more workers with
work-aggravated asthma than work-caused
asthma.
How the various types of work-related
asthma are defined often depends on the
setting (e.g., epidemiologic research, disease
surveillance, or workers' compensation). An
accepted operational definition of occupa-
tional asthma for clinical purposes is variable
airflow limitation and/or airway hyperrespon-
siveness due to exposure to a specific agent or
conditions in a particular work environment
and not to stimuli encountered outside the
workplace (1). This definition includes no
reference to the mechanism of asthma induc-
tion, and therefore work-related variable air-
way obstruction caused by antigen-induced
hypersensitivity reactions, pharmacologic
effects, nonspecific inflammatory processes,
and direct airway irritation can qualify as
occupational asthma. In the past, the term
occupational asthma often was used to refer
only to patients with reversible airflow limita-
tion due to sensitization to a substance
encountered at work (i.e., immunologic or
sensitizer-induced asthma) that involves a
latent period. With such an approach, work-
ers who develop persistent symptoms of
asthma and nonspecific airway hyper-
responsiveness promptly after short-term,
high-intensity inhalational exposure to irri-
tant materials would not be considered to
have occupational asthma. The term reactive
airways dysfunction syndrome (RADS) has
been coined to refer to this condition (24.
Recently, a consensus appears to be devel-
oping around the concept that there is a non-
immunologic type of occupational asthma
(without latency) that may occur after single or
multiple exposures to nonspecific irritant
chemicals at concentrations high enough to
induce airway injury and inflammation (1,3).
Because RADS refers only to asthma occurring
after a single high-intensity exposure, the term
irritant-induced asthma is used in this paper.
Recurrent exposure to an irritant before the
onset of asthmatic symptoms may lead to
blurring of the distinction based on latency.
Another type of disorder characterized by
work-related variable airways limitation is
associated with occupational exposure to
organic dusts such as cotton, flax, hemp, jute,
sisal, and various grains. Many but not all
occupational lung disease experts consider
organic dust-induced airways disease to be an
asthmalike disorder rather than true asthma
(1). Reasons for this distinction include lack
of airway eosinophilia, less frequent airway
hyperresponsiveness, and a tendency to
develop chronic bronchitis (by clinical defini-
tion) and chronic airflow limitation with
chronic exposure.
Occupational asthma may need to be
approached differently for epidemiologic and
disease surveillance purposes than for
medical-legal purposes. An inclusive
approach is appropriate for use in a surveil-
lance system in which identification triggers
an investigation or intervention. If prevention
of work-related asthma disability and loss of
productivity is the goal, then variable airflow
limitation and/or airway hyperresponsiveness
caused or aggravated by exposures at the
workplace must be considered.
Epidemiology
Reports from several surveillance programs
have suggested that occupational asthma is
probably the most common type of occupa-
tional lung disease in industrialized countries.
Occupational asthma accounted for 26% of
all work-related respiratory disease reported to
the Surveillance of Work and Occupational
Respiratory Disease (SWORD) program in
the United Kingdom (4) and 52% of such
cases in British Columbia, where there is a
particularly high prevalence due to the use of
western red cedar (5). The overall prevalence
of occupational asthma in the general popula-
tion, however, is not clearly known. In the
United States, analysis of 1978 Social Security
disability data indicated that approximately
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15% of individuals disabled from asthma
attributed it to workplace exposures (6).
A number of studies have attempted to
address the issue of attributable risk of
asthma or wheezing in the general popula-
tion due to occupation (i.e., what fraction of
all asthma is due to occupational exposures?).
This issue is complicated by the acknowl-
edged lack of a standardized definition of
asthma. A recent review of the existing litera-
ture on the population attributable risk of
asthma due to occupational exposures pro-
vided a range from 8 to 21% depending on
the definition of exposure (7).
The prevalence of occupational asthma
in various occupational cohort studies
depends on the agent(s) to which the work-
ers are exposed, levels of exposure, and host
suseptibility factors such as atopy and ciga-
rette smoking. The highest prevalences of
occupational asthma have been reported
with exposures to platinum salts and prote-
olytic enzymes used in the detergent indus-
try (up to 50%) (8,9). In general, however,
the prevalence of occupational asthma in
most cohorts of workers exposed to a known
sensitizing agent is less than 10% (10).
There are convincing data to indicate that
the level of exposure is an important risk
factor for sensitizer-induced occupational
asthma (10).
Atopy appears to be an important risk
factor for occupational asthma due to IgE-
dependent mechanisms. Psyllium workers
(11), bakers (12), and laboratory animal han-
dlers (13) who are atopic have been shown to
be at increased risk of developing occupa-
tional asthma compared to their non-atopic
co-workers. Cigarette smoking also appears to
increase risk of IgE-mediated occupational
asthma. Workers who smoke and have been
exposed to platinum salts, acid anhydrides,
snow crab, green coffee beans, and ispaghula
have been shown to have greater risk of devel-
oping occupational asthma than their non-
smoking coworkers (14). In contrast, for
most sensitizing agents that cause asthma
through mechanisms not involving specific
IgE antibodies, such as diisocyanates and
western red cedar, atopy and smoking do not
appear to be risk factors (15,16).
Little is known about the epidemiology of
irritant-induced asthma, but it is likely a rela-
tively rare outcome of irritant exposure.
SWORD data suggest that < 10% of reported
inhalational injuries are followed by persistent
asthma (17). Irritant exposures may deserve
greater attention as important preventable
causes of occupational asthma. Recent data
from the Sentinel Health Notification System
for Occupational Risk (SENSOR) program in
the United States indicate that exposures to
irritants are reported as frequently as expo-
sures to sensitizers as causes of new-onset
asthma (18). Level of exposure is likely to be a
risk factor for irritant-induced asthma. In a
study of hospital laboratory workers exposed
to a spill of glacial acetic acid, the risk of
irritant-induced asthma increased with level of
exposure as assessed by distance from the spill
(19). Several studies have also suggested that
atopy and smoking are risk factors for irritant-
induced asthma (20,21).
Pathogenesis/Mechanisms
Immunologic or Sensitizer-Induced
Occupational Asdtma
More than 250 agents have been adequately
documented as causing immunologic occupa-
tional asthma (27). Table 1 lists seme of the
more common agents and workers at risk.
The mechanisms of sensitization by which
these agents induce asthma can be somewhat
arbitrarily divided based on molecular weight
of the agents. High-molecular-weight
(HMW) compounds (. 5,000 Da) and some
low-molecular-weight (LMW) compounds
(< 5,000 Da), such as platinum salts and acid
anhydrides induce asthma by specific IgE
antibody-dependent reactions. However, use
of the term immunologic does not necessarily
imply an IgE-mediated response and cell-
mediated responses may be involved. IgE
antibodies specific for the sensitizing agent in
the workplace frequently cannot be demon-
strated in cases of occupational asthma caused
by LMW compounds such as diisocyanates
and plicatic acid (the agent responsible for
causing asthma in workers exposed to western
red cedar).
Whereas HMW compounds act as
complete antigens, LMW compounds must
react with proteins (autologous or hetero-
logous) to produce a complete antigen. In
IgE-mediated occupational asthma, inhaled
sensitizers bind to specific IgE on the surface
of mast cells, basophils, and probably
macrophages, eosinophils, and platelets. The
specific reaction between allergen and IgE
causes a cascade of events that produces the
activation of inflammatory cells. Mast-cell
activation leads to early bronchoconstriction
as a result of preformed mediator release (e.g.,
histamine; leukotrienes C4, D4, and E4; and
prostaglandin D2). IgE-dependent activation
of mast cells also leads to release of multiple
cytokines/chemokines and increased expres-
sion of various adhesion molecules that are
involved in modulating the late inflammatory
reaction after allergen exposure.
As noted previously, for a number of
LMW compounds, specific IgE compounds
either have not been found or have been
found only in a subset of affected workers. A
recent study using basophils from patients
with western red cedar showed that plicatic
acid did not induce histamine release from
basophils by a tyrosine kinase-mediated
mechanism as would be expected in an
IgE-dependent response (23). However, in a
companion study, it was shown that T lym-
phocytes from such patients specifically
responded to a conjugate of plicatic acid and
human serum albumin, suggesting an under-
lying immunologic mechanism (24).
Whether immunologic occupational
asthma is induced by HMW or LMW sensi-
tizers, T cells appear to play an important
role in the orchestration of the inflammatory
process, and eosinophils, mast cells, epithe-
lial cells, and neutrophils are the main effec-
tor cells that produce the characteristic
features of asthma (i.e., smooth muscle con-
traction, mucus hypersecretion, airway
inflammation, and epithelial injury). It has
been hypothesized that allergic asthma is
driven and maintained by the persistence of
a specialized subset of chronically activated
Table 1. Selected major causes of occupational asthma
and workers at risk.
Agents
Animals
Animal proteins
Prawns, crabs
Egg protein
Plants
Grain dust
Wheat, rye,
soy flours
Latex
Green coffee bean
Enzymes
Proteases from
Bacillus subtilis
Pancreatin, papain,
pepsin
Fungal amylase
Wood dusts
Western red cedar,
redwood
Chemicals
Diisocyanates
Acid anhydrides
Complex amines
Azodicarbonamide
Reactive dyes
Methyl methacrylate
Drugs
Penicillins, psyllium,
cimetidine
Metals
Platinum salts
Cobalt
Chromium, nickel
Other
Metal-working fluids
Aluminum potroom
emissions
Colophony in solder flux
Workers at risk
Animal handlers, laboratory
research workers
Processors of these foods
Egg producers
Grain storage workers
Bakers, millers
Health-care workers
Coffee roasters
Detergent industry workers
Pharmaceutical industry
workers
Bakers
Sawmill workers, joiners,
carpenters
Polyurethane, plastics,
varnish workers
Epoxy resins, alkyd resins,
plastics workers
Photographers, shellac
workers, painters
Plastics, rubber workers
Textile workers
Health-care workers
Pharmaceutical industry,
health-care workers
Platinum-refining workers
Hard-metal grinders
Metal-plating workers
Machinists
Aluminum-refining workers
Electronics workers
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T memory cells sensitized against aero-
allergenic, occupational, or viral antigens.
Studies showing proliferation of peripheral-
blood lymphocytes after stimulation with
cobalt and nickel (25) or diisocyanates (26)
in sensitized subjects support this hypothe-
sis. In nonoccupational allergic asthma, the
majority of T-cell clones derived from the
bronchial mucosa are CD4+, whereas in
diisocyanate-induced asthma, the majority
are CD8+ (27). Interestingly, an increased
percentage of CD8+ T cells and increased
production of interleukin (IL)-5 have been
found in bronchoalveolar lavage fluid from
nonatopic asthmatics (28).
Recent investigations into the genetic
determinants of risk for sensitizer-induced
occupational asthma suggest that polymor-
phisms in genes encoding major histocom-
patibility complex (MHC) class II proteins
may be important determinants of the
specificity of response to sensitizing agents.
In workers with exposure to diisocyanates,
HLA-DQB1*0503 and DQB1*0201/0301
alleles are associated with asthma, whereas
HLA-DQB1*O501 and DQA1*0101-
DQB1*0501-DR1 appear to be protective
(29). The alleles, HLA-DQB1*0503 and
HLA-DQB1*0501, differ at residue 57 for
a single amino acid, aspartic acid in
DQB1*0503 and valine in DQB1*0501,
suggesting that residue 57 may be a poten-
tially critical location in the development of
asthma (30). Associations with MHC pro-
teins have also been described in acid
anhydride-induced asthma (31), in plat-
inum salts-induced asthma, and in red
cedar-induced asthma (32). The DRB 1 * 13
marker was associated with the risk of soy-
bean epidemic asthma in Barcelona, Spain
(33), and the phenotype frequencies of
DRI and DR4 are slightly increased in
subjects sensitized to latex (34).
Nonimmunologic or Irritant-Induced
Occupational Asthma
The mechanisms of irritant-induced
asthma are largely unknown, but a localized
airway inflammatory response is likely
involved. It is important to note that most
patients who have sustained a toxic inhala-
tional injury to their airways (chemical
bronchitis) will recover without developing
asthma. There are bronchial biospy data
from patients who developed clinically evi-
dent asthma after exposure to high concen-
trations of irritants (e.g., RADS) that
suggest that the histopathologic changes are
similar to those of typical asthma, i.e.,
subepithelial fibrosis and infiltration of the
mucosa/submucosa by eosinophils and
T cells. However, the fibrosis tends to be
greater and the T-cell infiltration/activation
tends to be less (2,35,36).
It has been hypothesized that irritant-
induced epithelial damage is followed by
direct activation of nonadrenergic, noncholin-
ergic pathways via axon reflexes and onset of
neurogenic inflammation (37). Nonspecific
macrophage activation and mast cell degranu-
lation may also occur. Recruitment of other
inflammatory cells likely enhances the inflam-
matory response. The damaged bronchial
epithelium may contribute to the persistence
of the inflammatory response by release of
proinflammatory mediators but also may
exhibit impaired function (e.g., reduced neu-
tral endopeptidase activity, decreased genera-
tion of epithelial-derived relaxing factor).
Irritant-induced airway inflammation may
alter epithelial permeability such that subep-
ithelial irritant receptors are more likely to be
exposed to nonspecific stimuli such as cold air,
exercise, cigarette smoke, and other inhaled
irritants. Stimulation of these receptors may
further increase the likelihood of persistence
of airway inflammation and nonspecific air-
way hyperresponsiveness. Recovery from irri-
tant-induced asthma appears to occur over
time in many cases. However, the greater the
initial injury, the more unlikely that complete
recovery will occur. With severe injury,
whether after a single high-concentration
inhalation or multiple low-concentration
exposures, there may be sufficient airway
remodeling (i.e., deposition of type III colla-
gen under the basement membrane) that
complete recovery cannot occur.
Although much has been learned about
the pathogenetic mechanisms underlying the
various types of occupational asthma, little of
this information has clinical applicability at
this point because of important data gaps.
This caveat is especially relevant to the issue of
testing of workers for genetic susceptibility.
Such testing cannot be recommended because
there is not sufficient understanding of the
interactions among genetic and environmental
determinants of risk of occupational asthma.
Diagnosis
The diagnosis of occupational asthma is made
by confirming the diagnosis of asthma and by
establishing a relationship between asthma
and work (38-41). Occupational asthma
should be considered in every case of adult-
onset asthma or asthma that worsens in adult
life (15,40).
Making a diagnosis of asthma requires the
presence of both intermittent respiratory
symptoms (e.g., cough, wheezing, chest tight-
ness, and/or dyspnea) and physiologic
evidence of reversible/variable airways
obstruction or hyperresponsiveness. After the
diagnosis of asthma is confirmed, the next
step is to assess the patient's relationship with
work, preferably by means of objective tests.
In general, the patient's history alone is not
sufficient for the diagnosis of occupational
asthma and is more likely to exclude than to
confirm the diagnosis of occupational asthma
(38,42). Objective confirmation of the diag-
nosis is necessary for both appropriate med-
ical care and compensation purposes. It is
important to recognize that no single test can
be used to confirm the diagnosis in all cases.
Clinical Picture
Patients with occupational asthma may
present with varying degrees of respiratory
compromise, from mild symptoms to moder-
ate or severe bronchospasm. In general, occu-
pational asthma presents clinically in the
same way as asthma of non-occupational ori-
gin. Mild cases of asthma may present with
only episodic dry cough, chest tightness, and
increased breathing effort. Signs and symp-
toms in more severely affected patients
include wheezing, cough, chest tightness,
shortness of breath, and dyspnea on exertion.
Some patients with occupational asthma
develop work-related bronchitis, character-
ized by recurrent episodes of cough and spu-
tum production. Others may experience
nocturnal awakening as an early manifesta-
tion of occupational asthma.
Rhinoconjunctivitis, which is manifested
by ocular and nasal discharge and pruritus,
and sneezing, may accompany respiratory
symptoms. In a study comparing the occur-
rence of rhinoconjunctivis symptoms in
workers exposed to HMW versus LMW sub-
stances, it was found that rhinoconjunctivitis
occurred prior to the onset of occupational
asthma in workers exposed to HMW sub-
stances; those exposed to LMW substances
developed symptoms concurrently with their
respiratory symptoms. It was postulated that
HMW substances are more likely to invoke
IgE-mediated immune responses that result
in this temporal symptom pattern (43).
In immunologic or sensitizer-induced
occupational asthma, symptoms typically
develop months or years after the onset of
exposure. Substances that cause sensitizer-
induced asthma may induce early, late, or
dual airway responses (Figure 1). An early
asthmatic reaction begins within a few min-
utes of inhalation, with maximal bron-
choconstriction occurring within 30 min.
Late asthmatic reactions occur within 4-8 hr
of inhalation. Dual, or biphasic, asthmatic
reactions are characterized by both early and
late bronchoconstriction. IgE-dependent
agents such as HMW substances, may
induce both early and biphasic reactions
(15,44). IgE-independent agents are more
likely to induce late or biphasic reactions
(15,44). These patterns of airway responses
are most clearly demonstrated in controlled
exposure settings rather than in typical work-
place settings, which are more likely to
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Figure 1. Potential responses to inhaltion of sensi-
tizing agent in patients with immunologic occupa-
tional asthma.
involve exposures that vary over the course of
the day and work week.
Nonimmunologic or irritant-induced
asthma is caused by exposure to gases, fumes,
mists, smoke, or dusts that are directly irritat-
ing to the airways. Chemical bronchitis often
precedes the development of irritant-induced
asthma. In RADS, asthmatic symptoms occur
relatively promptly and persistently after a
single, high-concentration inhalational expo-
sure. In irritant-induced asthma involving
multiple lower-concentration exposures,
while recurrent symptoms of mucosal irrita-
tion are often experienced earlier, symptoms
of asthma may be more gradual in onset.
History and Fposure Assessment
As in the evaluation of any patient with a
possible work-related injury or illness, the
evaluation of occupational asthma includes a
detailed medical and occupational history. In
the history of the present illness, the temporal
relationship between recent exposures and res-
piratory symptoms must be investigated. A
relationship between asthmatic symptoms and
workplace exposures is suggested if any of the
following patterns are present: symptoms that
occur only at work; symptoms that improve
on weekends or vacations; symptoms that
occur regularly after the workshift; symptoms
that progressively increase over the course of
the work week; and symptoms that improve
after a change in the work environment (39).
Potential exposures to all "asthmagens" in
the workplace as well as the home environ-
ment should be assessed. Workers also must
be queried regarding any jobs in addition to
their full-time employment and/or hobbies
that might expose them to other asthmagens.
Specific occupational history questions
include not only the job title of the worker
but also specific job duties performed. In
event of accidents or spills, information
regarding the role the worker played, proxim-
ity to the point source, size of the room, venti-
lation, duration of exposure, and type and
efficacy of respiratory protection, i.e., personal
protective equipment, should be evaluated.
Evaluation also should include assessing the
intensity or magnitude of exposure including
review of available industrial hygiene records,
types of industrial processes used, such as
those involving chemicals with high vapor
pressure or heating; job characteristics such as
spray painting, and geographic and climactic
factors. In addition, other workers who have
developed episodic respiratory symptoms
must be identified, and their complete
chronologic occupational histories obtained.
Past medical histories should focus on any
history of asthma, including current and past
medications, (e.g., frequency of use, patterns
of use in relation to work), a history of hospi-
talizations or emergency room evaluations,
and intubations. Other pertinent history
includes childhood asthma, allergic rhinitis,
atopic dermatitis, and other respiratory con-
ditions such as chronic obstructive pul-
monary disease. Cardiac history, including
angina, and gastrointestinal history, including
gastroesophageal reflux, which may present
with episodic dyspnea, must also be evalu-
ated. A history of allergies, previous allergy
testing, and cigarette smoking should be
assessed, as should a history of airway hyper-
responsiveness to nonallergenic stimuli such
as exercise, cold air, or irritants.
Physical Examination
The physical examination of a patient with
asthma is frequently completely normal.
Physical examination should be focused on
the upper and lower respiratory tract, includ-
ing visualizing nasal and oropharyngeal
mucous membranes, palpating the sinuses,
and inspecting for nasal polyps. The chest
should be auscultated during quiet breathing
and forced exhalation, noting wheezes,
rhonchi, or crackles. Cardiac examination
should be performed to exclude a cardiac eti-
ology for respiratory distress. The skin should
be inspected for eczematous dermatitis and
the extremities inspected for clubbing,
cyanosis, and edema.
Objectiw Tests
Most asthmatic patients have normal chest
radiographs because asthma involves the air-
ways rather than the lung parenchyma.
During exacerbations, hyperinflation and
flattening of the diaphragms may be visual-
ized because of air trapping. Bronchial wall
thickening, reflecting chronic inflammation,
and mucus plugging, manifested by fleeting
infiltrates, may be observed.
As there are no physical examination
findings specific for asthma and work-
related wheezing is difficult to detect,
repeated pulmonary function testing (both
at and away from work) is usually required
to make the diagnosis of occupational
asthma. Spirometry, both pre- and post-
bronchodilator, is the most reliable method
of determining the presence of airflow limi-
tation. It can be used to measure the
response to a bronchodilator, which gener-
ally confirms the diagnosis of asthma. The
American Thoracic Society defines a 12%
improvement in the FEV, (forced expira-
tory volume in 1 sec) or an absolute value
increase of at least 200 mL after bron-
chodilator administration as evidence of
reversibility of airflow limitation (45). A
decrease of 10% in the FEV, across a work
shift is objective evidence for work-related
bronchoconstriction (46).
Peak expiratory flow (PEF), which is
measured in liters/minute via a hand-held
peak flow meter, is a simple and inexpensive
method to assess airflow limitation and can
be performed by the patient outside medical
or work settings. The patient is instructed to
exhale as forcefully as possible into this
device, preferably at least four times per day,
prior to work, during various times in the
work shift, after work, and prior to bedtime.
In addition, the patient is asked to maintain a
symptom diary, recording the time of day,
the PEF reading, and any respiratory symp-
toms; these are evaluated by a physician on
medical follow-up. At least 2 weeks of serial
PEF recordings are needed to assess whether
occupational asthma is likely. A 20% or
greater diurnal variability in PEF has been
used to diagnose workers with occupational
asthma and a computerized system of analysis
is under development, but at present, visual
inspection of whether there is a work-related
pattern of increased diurnal variability is
probably the best approach to the analysis of
serial peak flow recordings (38,44).
Currently there is debate about whether
PEF readings are accurate, as they are depen-
dent on patient effort and reliability. In a
study of 17 subjects instructed in the use of
a portable computerized peak flow meter
who were unaware that their readings were
being stored by the flow meter, it was found
that only 55% of the records were com-
pletely accurate in terms of the recorded
value and timing of the measurements (48).
Worker training may improve the accuracy
of measurements (49) and portable comput-
erized peak flow meters are becoming
increasingly affordable. Despite concerns
about accuracy of patient-recorded PEF
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data, some investigators have found such
data to have reasonable sensitivity and speci-
ficity for the diagnosis of occupational
asthma (47,50).
In a worker suspected of having occupa-
tional asthma but who has normal spirometry,
inhalation challenge testing with metha-
choline or histamine can demonstrate the
presence of nonspecific airway hyperrespon-
siveness. Progressive doses of histamine or
methacholine are administered to the patient
and serial FEVy measurements are obtained to
generate a dose-response curve. The PC20 is
the provocative concentration of histamine or
methacholine that induces a 20% drop in
FEVI, after which the test is terminated. This
test can be performed on an outpatient basis
and several published protocols are available
(51). On occasion, workers with occupational
asthma do not show clear evidence of work-
related lung function changes until after a pro-
longed period of removal from the causative
exposure. In other words, it may take several
weeks away from the usual workplace before
noticeable improvement is noted in the
patient's spirometry, PEF, and/or metha-
choline responsiveness.
Specific inhalation challenge tests, also
called specific bronchial provocation
studies, are rarely performed in the United
States. When performed, the purpose of a
specific challenge is often to determine the
precise etiology in a complex exposure sce-
nario or to investigate an unreported sensitizer.
Historically, a specific inhalation challenge test
has been considered a potentially dangerous
procedure because the specific agent thought to
induce occupational asthma is administered to
the subject. These should be administered in a
tightly controlled situation with careful moni-
toring in a hospital setting. However, recent
studies in Quebec indicate that if stringent
exposure and safety protocols are followed, spe-
cific inhalation challenge tests can be per-
formed with minimal risk to the subjects (52.
Atopy, which is a risk factor for HMW
sensitizer-induced asthma, can be established
by administering skin prick tests with common
aeroallergens. Extracts are available for con-
firming immediate hypersensitivity to some
occupational sensitizers such as flour, animal
proteins, and coffee. Patients can also be tested
for the presence of specific IgE antibodies
against HMW and some LMW sensitizers
(diisocyanates, acid anhydrides).
Diagnostic Criteria
As noted previously, the diagnosis of occupa-
tional asthma involves confirming the diagnosis
of asthma and suggested work-relatedness. The
American College of Chest Physicians sug-
gested the following criteria in 1995 for estab-
lishing a diagnosis of occupational asthma: a
history compatible with occupational asthma;
the presence of airflow limitation and its
reversibility; in the absence of airflow limita-
tion, the presence of nonspecific airway hyper-
responsiveness; and the demonstration of
work-relatedness of asthma by objective means
(38). The Canadian Thoracic Society has sug-
gested a similar approach in making the diag-
nosis ofoccupational asthma, by demonstrating
the presence of asthma with pulmonary func-
tion tests and then assessing the relationship
between asthma and work (40).
The National Institute for Occupational
Safety and Health has recently updated its
surveillance case definition and surveillance
classification criteria for its state-based
SENSOR programs for work-related asthma,
which currently exist in California,
Massachusetts, Michigan, and New Jersey
(17). Sentinel health events, which include
cases of work-related asthma, indicate the
need for preventive measures. Surveillance of
work-related asthma may be accomplished by
requiring health care professionals to report
all diagnosed or suspected cases to state health
departments. In analysis of these cases, the
relative frequencies of classes of work-related
asthma can be determined, as can gender fre-
quencies, specific asthma-inducing agents,
whether previously known or newly discov-
ered, and the most common industries in
which workers develop work-related asthma.
The SENSOR surveillance case definition
for state health departments for work-related
asthma includes: a) a health care profes-
sional's diagnosis consistent with asthma, and
b) an association between symptoms of
asthma and work. The SENSOR programs
classify work-related asthma into three broad
categories by using surveillance case classifica-
tion criteria. These classes include occupa-
tional asthma, or work-induced asthma
which is new in onset; work-aggravated
asthma, which occurs in workers with pre-
existing asthma that has been treated within
the past two years; and RADS, or irritant-
induced asthma. The SENSOR case classifi-
cation criteria are as follows:
* Work-aggravated asthma is defined as
preexisting asthma that was symptomatic
and/or treated with asthma medication
within the 2 years prior to entering the
occupational setting associated with the
patient's asthma symptoms.
* RADS is defined as new asthma symp-
toms that develop within 24 hr after a
one-time high-level inhalation exposure
(at work) to an irritant gas, fume, smoke,
or vapor and that persist for at least 3
months.
* Occupational or work-induced asthma is
defined as:
a) workplace exposure to an agent previ-
ously associated with occupational
asthma; or
b) work-related changes in serially measured
FEV, or PEF; or
c) work-related changes in bronchial
responsiveness as measured by serial non-
specific inhalation challenge testing; or
d) positive response to specific inhalation
challenge testing with an agent to which
the patient has been exposed at work.
Although the SENSOR surveillance case
definition and classification criteria were
designed for specific epidemiologic purposes,
they provide a reasonable approach for the
clinical evaluation of patients.
Management
The mainstay of treatment for occupational
asthma is prompt diagnosis and removal of
the worker from further exposure to the incitr
ing agent if substitution with a less hazardous
substance is not possible (15,38-40,44). This
is crucial in cases of sensitizer-induced occu-
pational asthma, as very low exposures may
trigger asthmatic reactions including status
asthmaticus. Substances such as toluene diiso-
cyanate have been reported to induce asthma
in sensitized workers in the parts-per-billion
range. Workers with irritant-induced or
work-aggravated asthma may continue to
work in their usual jobs if their exposure to
the inciting agent is diminished through
proper engineering controls or respiratory
protective equipment if engineering controls
are not feasible.
General Asthma Management
Patients diagnosed with occupational asthma
should have medical management following
published guidelines (53). Since asthma is
characterized by airway inflammation, inhaled
corticosteroids have become a mainstay of
treatment. Malo and colleagues (54) demon-
strated that inhaled corticosteroids induce a
small but significant overall improvement
after withdrawal from exposure of patients
with sensitizer-induced occupational asthma
due to both HMW and LMW agents. In their
double-blind crossover study, it was found
that inhaled steroids were more beneficial if
administered earlier rather than later after the
diagnosis of occupational asthma.
Work Implications and Progosis
Occupational asthma can become a very
disabling disease, resulting in long-term ill-
ness and a high rate of unemployment (55).
Subjects with occupational asthma suffer
increased hospitalization rates for all causes,
including cardiac and respiratory disease,
compared to patients without asthma but
lower hospitalization rates than among
patients with nonoccupational asthma at a
tertiary care center (56). Quality-of-life ques-
tionnaires have been administered to subjects
with occupational asthma and compared to
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those of patients with nonoccupational
asthma. Subjects with occupational asthma
have statistically significant impairments in
quality of life. They demonstrate increased
asthma symptoms, increased limitation of
activities, and increased emotional dysfunc-
tion. These dinical and functional variables
may diminish with decreased severity of
asthma, loss of usual job, need for job retrain-
ing, or need for early retirement (57).
Multiple studies have confirmed that
most workers with sensitizer-induced occupa-
tional asthma do not completely recover even
after cessation of exposure to the causative
agent (58,59). Persistent nonspecific airway
hyperresponsiveness is frequent and is associ-
ated with chronic airway inflammation. Risk
factors for persistent asthmatic symptoms and
airway hyperresponsiveness are duration of
exposure, duration of symptoms before
removal from exposure, and severity of
asthma at time of diagnosis (58,60). Early
removal from exposure to a sensitizer
increases the likelihood of recovery, and con-
tinued exposure in sensitized workers is asso-
ciated with a worsening ofasthma (61).
With cessation of exposure, spirometry
and airway responsiveness tend to improve
over time. In general, spirometric measures
plateau in 1 year and bronchial responsive-
ness plateaus in 2 years (62. Lemiere and col-
leagues (63) found that a majority of subjects
(60%) demonstrated decreased but persistent
specific airway responsiveness after removal
from exposure to the offending agent.
Cessation of exposure to toluene diisocyanate
in sensitized workers with occupational
asthma is associated with a decrease in both
the number of inflammatory cells in the air-
way mucosa and in the amount of subepithe-
lial fibrosis observed with serial bronchial
biopsies (64).
Follow-up data on workers with irritant-
induced asthma are sparse, but in one study a
majority of pulp mill workers who developed
symptoms of asthma after acute "gassing"
episodes continued to have nonspecific airway
hyperresponsiveness up to 2 years following
their last exposures (65).
Impairment/Disability Assessment
Because the majority of workers with occupa-
tional asthma continue to have some degree
of respiratory impairment even several years
after cessation of exposure, disability (i.e.,
decreased ability to work in one's usual and
customary job, or if severe, in any job) is a
common outcome. Rates of job loss or job
change are high (66-70). Disease severity
plays a major role, but working conditions are
a potent factor in determining who experi-
ences disability and who does not (71-73). As
a consequence of this high rate of disability,
occupational asthma often has a substantial
socioeconomic impact, with one study (69)
finding that approximately 50% of affected
workers suffered a reduction in income
3 years after the diagnosis was made.
Physicians are often asked to assist their
patients diagnosed with occupational asthma
to obtain workers' compensation for any dis-
abilities caused by the disease.
Evaluation of level of impairment due to
occupational asthma should be carried out as
soon as the condition has been optimally
treated and stabilized. Guidelines for impair-
ment evaluation have been developed by the
American Thoracic Society and endorsed by
the American Medical Association (74,75).
These guidelines use a scoring system that
involves the following categories: postbron-
chodilator FEV1, reversibility of FEV1 or
degree of nonspecific airway hyperresponsive-
ness, and minimum asthma medication need
for optimal control of the disease. Ideally,
follow-up evaluation should again be carried
out when there is a change in dinical status.
Prevention
Prevention must be the primary tool for
decreasing the incidence of and morbidity and
disability from, occupational asthma, which
can become a chronic disabling disease.
Prevention must involve the expertise of occu-
pational health personnel, industrial hygien-
ists, engineers, chemists, and allergists (76). It
must also involve cooperation between
employers, workers and their representatives,
regulators, and medical personnel (77).
The goal of primary prevention is to
prevent occupational exposure. Primary pre-
vention methods indude eliminating the sen-
sitizing agent altogether by substitution with
less hazardous substances, changing industrial
processes, or reducing exposures. Secondary
prevention detects asthma early so that its
duration and severity can be minimized. The
early detection of asthma in workers in high-
risk industries such as the spray-painting
industry where there is high exposure to
diisocyanates is an example of secondary pre-
vention. Tertiary prevention applies to indi-
viduals who have already been diagnosed with
occupational asthma. It includes institution
of appropriate health care and an effort to
prevent permanent asthma by early removal
of the subject from exposure (77).
Unfortunately, although removing of workers
from the vicinity of the asthma-inducing
agent may lead to symptomatic improve-
ment, it may not prevent persistent asthma.
Engineering controls may be instituted to
lower the risk of exposure to irritants and sen-
sitizers when substitutes cannot be found.
Such controls include local exhaust ventila-
tion, process endosure, containment/isolation
of hazardous exposures, and maintenance
programs. Personal protective equipment
such as respirators should only be considered
measures of last resort. As in any industry
with potential work-related hazards, proper
worker education and training in work
processes, safety equipment and procedures,
and the use of material safety data sheets are
of utmost importance.
Worplac Sureilnce
Another essential component in the preven-
tion of occupational asthma is surveillance for
occupational asthma in the workplace.
Surveillance programs are a type of secondary
prevention in that their principal goal is the
early detection of asthma. In making an ear-
lier diagnosis, morbidity and disability can be
prevented through timely intervention. Any
diagnosis of occupational asthma must be
considered a sentinel event; other exposed
workers are at risk and need to be identified
promptly (18,40,46).
A general approach to surveillance
programs includes medical screening of
co-workers as well as exposure monitoring
(40,46,77). The former falls under the juris-
diction of a medical department, whereas the
latter is performed by industrial hygiene pro-
fessionals. Ideally, both the medical and
industrial hygiene components should be per-
formed in tandem. Performing surveillance in
high-risk industries such as those using diiso-
cyanates is a prime example. In medical sur-
veillance, short symptoms questionnaires can
be administered annually and should include
questions about whether improvement occurs
in respiratory symptoms on weekends and
holidays (40,46,77). In addition, periodic
spirometry can be performed on an annual
basis and compared to baseline spirometric
testing at the time of the worker's hire.
Review of PEF records over several weeks can
also detect workers at risk for developing
occupational asthma. Industrial hygienists
can perform air sampling to ensure that
appropriate engineering controls are in place
to protect workers. Reviewing and updating
lists of agents used in a given industry should
be performed on a periodic basis to identify
possible asthma-inducing agents.
In Ontario, Canada, diisocyanate expo-
sures had been the most common cause of
occupational asthma in workers' compensa-
tion daims up to 1988. Subsequently initiated
medical and industrial surveillance programs
have resulted in earlier removal of diiso-
cyanate-exposed workers, thus shortening the
duration of their asthmatic symptoms (78).
Medical screening can also include skin-
prick testing in high-risk industries. Skin
testing is available for some HMW antigens
such as flours, proteolytic enzymes, and labo-
ratory animal proteins. Questionnaires can be
administered that address allergic symptoms,
skin sensitization, and respiratory symptoms.
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Cross-shift spirometry can detect workers
with acute work-related decrements in FEV1
but is insensitive for detecting late responses
that may occur after work hours and requires
on-site medical personnel for administration
of the tests. Annual methacholine challenge
testing has some theoretical appeal but is
impractical to apply to a large number of
exposed workers.
Future Research Needs
Although much insight into the pathogenesis
of sensitizer-induced asthma has been gained
over the past several decades, a better under-
standing of the mechanism(s) underlying
asthma due to exposure to LMW-sensitizing
agents such as the diisocyanates is needed. Of
even greater need is a data-based framework
for understanding the pathogenesis of irritant-
induced asthma. Development of appropriate
animal models would be a major advance.
Although considerable progress has been made
with regard to models ofHMW sensitizer-
induced asthma, models ofLMW sensitizer-
induced asthma (79) and irritant-induced
asthma following a single high-concentration
exposure are still in a relatively early stage of
development (80). To date, there is no model
of irritant-induced asthma due to multiple
lower concentration exposures.
Longitudinal studies of incident cases of
asthma that are population based and allow
work relatedness to be determined would
provide the best approach to the question of
how much asthma is due to occupational
exposures. More research into potential
interactions between occupational exposures
and nonoccupational factors such as genetic
susceptibility, smoking, and viral infections
in the development of occupational asthma
is also needed. Despite some important
efforts with regard to HMW sensitizers
(81,82), more exposure-response data on
LMW sensitizers and irritants is critical to
developing effective primary prevention pro-
grams. Development of medical surveillance
protocols and interventions with docu-
mented efficacy in reducing new cases of
occupational asthma in high-risk settings is a
key research priority. Better data on the
long-term course of irritant-induced asthma,
especially the efficacy of inhaled steroids in
improving outcome, would be of great value
in managing patients with this condition.
Finally, validation of the American Thoracic
Society/American Medical Association
guidelines for assessing disability due to asthma
would also be an important contribution.
Summary
Occupational asthma is currently the most
common form of occupational lung disease in
the developed world. The prevalence of this
disease is likely to remain high for many years
because about 250 industrial agents are
known to cause the disease and new chemi-
cals are continuously being introduced into
the workplace. Diagnosis of occupational
asthma is generally established on the basis of
a history that suggests a temporal association
between exposure and the onset of symptoms
and objective evidence that these symptoms
are related to airflow limitation. Current evi-
dence suggests that early diagnosis, elimina-
tion of exposure to the responsible agent,
and early use of inhaled steroids may play
important roles in preventing the long-term
persistence of asthma.
Persistent occupational asthma is often
associated with substantial disability and con-
sequent impacts on income and quality of
life. Prevention of new cases is the best
approach to reducing the burden of asthma
attributable to occupational exposures.
Despite considerable advances in our under-
standing of occupational asthma, more
research is needed on pathogenesis, risk fac-
tors, exposure-response, long-term outcome,
and effective preventive strategies.
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